← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Hagan Patrick G
Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001703852
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 3
- Purchases · 24M
- 9
- Average purchase
- $5.1K
- Median purchase
- $5.5K
- Gross purchase value
- $45.8K
Companies: AMES NATIONAL CORP
9 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-05-15 | AMES NATIONAL CORP | ATLO | Director | $5.5K | Open filing |
| 2026-05-12 | AMES NATIONAL CORP | ATLO | Director | $2.8K | Open filing |
| 2025-10-24 | AMES NATIONAL CORP | ATLO | Director | $6.3K | Open filing |
| 2025-05-22 | AMES NATIONAL CORP | ATLO | Director | $3.5K | Open filing |
| 2025-04-28 | AMES NATIONAL CORP | ATLO | Director | $8.3K | Open filing |
| 2024-12-13 | AMES NATIONAL CORP | ATLO | Director | $3.4K | Open filing |
| 2024-11-04 | AMES NATIONAL CORP | ATLO | Director | $1.7K | Open filing |
| 2024-10-25 | AMES NATIONAL CORP | ATLO | Director | $5.5K | Open filing |
| 2024-10-23 | AMES NATIONAL CORP | ATLO | Director | $8.8K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 9Developing | 100.0% (9/9) | 66.7% (6/9) | +0.3% | +1.1% | -3.1% |
| 20D | 9Developing | 100.0% (9/9) | 77.8% (7/9) | +3.9% | +3.6% | -2.1% |
| 60D | 9Developing | 100.0% (9/9) | 77.8% (7/9) | +5.6% | +5.5% | -6.5% |
| 120D | 7Developing | 100.0% (7/7) | 85.7% (6/7) | +8.2% | +11.3% | -2.5% |
Research patterns
- First purchase in 12M
- 0/8
- Large purchase ≥ $100k
- 0/9
- Cluster buying · 15D
- 7/9
- Buying the dip
- 3/9
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.